Sir i am very glad to know about the news please let me know where in india it is available as i am a total visual impaired person with retinitis pigmentosa regards subramanyam -----Original message----- From: Singhal, Vivek Sent: 04/10/2013, 10:15 To: 'accessindia@accessindia.org.in' Subject: [AI] Google Alert - Retinitis Pigmentosa
News 2 new results for Retinitis Pigmentosa Sun Pharma inks JV with US-based Intrexon Corp to develop gene ...<https://www.google.com/url?q=http://articles.economictimes.indiatimes.com/2013-10-02/news/42617501_1_sun-pharma-retinitis-pigmentosa-synthetic-biology&ct=ga&cd=OTgwNzEzNDMyMjAxMjY3NDA2OQ&cad=CAEYAA&usg=AFQjCNF11-R1jsdp2gvvosG_ZFxgmtHt4A> Economic Times MUMBAI: Sun Pharma, India's biggest drugmaker by market cap, has signed a joint venture with the US-based Intrexon Corporation, a leader in synthetic ... See all stories on this topic » <https://www.google.com/url?q=http://news.google.com/news/story%3Fncl%3Dhttp://articles.economictimes.indiatimes.com/2013-10-02/news/42617501_1_sun-pharma-retinitis-pigmentosa-synthetic-biology%26hl%3Den%26geo%3DUS&ct=ga&cd=OTgwNzEzNDMyMjAxMjY3NDA2OQ&cad=CAEYAA&usg=AFQjCNHnsAjrGSBRS0o5ERXQWyK-cKVXGQ> [http://t3.gstatic.com/images?q=tbn:ANd9GcTlLEEmMWtXDgIRitBPCHkRTIkqgbfDbczRKWpG7a2lKT-cKb6p3ux-X4k]<https://www.google.com/url?q=http://economictimes.indiatimes.com/markets/stocks/stocks-in-news/sun-pharma-gains-on-jv-to-develop-new-drugs/articleshow/23443997.cms&ct=ga&cd=OTgwNzEzNDMyMjAxMjY3NDA2OQ&cad=CAEYAA&usg=AFQjCNHzycruMIE-_UQliPu4Gvch8BwVHw> Economic Times<https://www.google.com/url?q=http://economictimes.indiatimes.com/markets/stocks/stocks-in-news/sun-pharma-gains-on-jv-to-develop-new-drugs/articleshow/23443997.cms&ct=ga&cd=OTgwNzEzNDMyMjAxMjY3NDA2OQ&cad=CAEYAA&usg=AFQjCNHzycruMIE-_UQliPu4Gvch8BwVHw> Dompé Announces the Food and Drugs Administration (FDA) Has ...<https://www.google.com/url?q=http://www.lifescience-online.com/Domp__Announces_the_Food_and_Drugs_Administration_,38137.html%3FportalPage%3DLifescience%2520Today.News&ct=ga&cd=OTgwNzEzNDMyMjAxMjY3NDA2OQ&cad=CAEYAQ&usg=AFQjCNFEneGdriasuvxzX0E36XJta6-NbA> Lifescience-online Dompé Announces the Food and Drugs Administration (FDA) Has Granted Orphan Drug Designation to its rhNGF-based Treatment for Retinitis Pigmentosa. See all stories on this topic » <https://www.google.com/url?q=http://news.google.com/news/story%3Fncl%3Dhttp://www.lifescience-online.com/Domp__Announces_the_Food_and_Drugs_Administration_,38137.html%253FportalPage%253DLifescience%252520Today.News%26hl%3Den%26geo%3DUS&ct=ga&cd=OTgwNzEzNDMyMjAxMjY3NDA2OQ&cad=CAEYAQ&usg=AFQjCNHguHjT48a3qix2JWeit4jh2oKB3A> ________________________________ Manage<http://www.google.com/alerts/manage?cd=OTgwNzEzNDMyMjAxMjY3NDA2OQ&cad=CAE&source=alertsmail&hl=en&gl=US&s=AB2Xq4iJiBY6OzjXh4EtrukeWqoC1FDsSi7iOeY> your alerts. ________________________________ This Message was sent from Indian Oil Messaging Gateway, India. The information contained in this electronic message and any attachments to this message are intended for the exclusive use of the addressee(s) and may contain proprietary, confidential or privileged information. If you are not the intended recipient, you should not disseminate, distribute or copy this e-mail. Please notify the sender immediately and destroy all copies of this message and any attachments. ________________________________ Register at the dedicated AccessIndia list for discussing accessibility of mobile phones / Tabs on: http://mail.accessindia.org.in/mailman/listinfo/mobile.accessindia_accessindia.org.in Search for old postings at: http://www.mail-archive.com/accessindia@accessindia.org.in/ To unsubscribe send a message to accessindia-requ...@accessindia.org.in with the subject unsubscribe. To change your subscription to digest mode or make any other changes, please visit the list home page at http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in Disclaimer: 1. Contents of the mails, factual, or otherwise, reflect the thinking of the person sending the mail and AI in no way relates itself to its veracity; 2. AI cannot be held liable for any commission/omission based on the mails sent through this mailing list.. Register at the dedicated AccessIndia list for discussing accessibility of mobile phones / Tabs on: http://mail.accessindia.org.in/mailman/listinfo/mobile.accessindia_accessindia.org.in Search for old postings at: http://www.mail-archive.com/accessindia@accessindia.org.in/ To unsubscribe send a message to accessindia-requ...@accessindia.org.in with the subject unsubscribe. To change your subscription to digest mode or make any other changes, please visit the list home page at http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in Disclaimer: 1. Contents of the mails, factual, or otherwise, reflect the thinking of the person sending the mail and AI in no way relates itself to its veracity; 2. AI cannot be held liable for any commission/omission based on the mails sent through this mailing list..
